The company knew of safety issues associated with its Recovery IVC filter. A year-long investigation by NBC News raises concerns about an IVC filter manufactured by C.R. Bard. The first part of the series, which aired on September 2nd, suggests that the company knew of safety issues associated with its Recovery IVC filter but failed to disclose this information to the public.
The Recovery filter is designed is intended prevent pulmonary embolism by stopping blood clots from reaching the lungs. The retrievable IVC is implanted in the inferior vena cava. Recovery, which was introduced in 2003, has been named in a number of lawsuits alleging the defects of the device has injured patients.
NBC reports that the Recovery IVC filter is associated with over 300 patient complications and 27 deaths over the course of a decade. Additionally, the investigation highlighted evidence showing Bard was aware of the risk of adverse events but chose to withhold this information from the public. The report cited a confidential study commissioned by Bard in 2004 showing that the filter was linked to a higher risk of death, fracture and movement compared to competitors. Instead of issuing a recall, the company sold an additional 34,000 units. The products was then replaced with the G2 filter system, which has also been named in numerous lawsuits.